179 related articles for article (PubMed ID: 36181275)
1. Exploration of a predictive model based on genes associated with fatty acid metabolism and clinical treatment for head and neck squamous cell carcinoma.
Yuan Z; Huang J; Teh BM; Hu S; Hu Y; Shen Y
J Clin Lab Anal; 2022 Nov; 36(11):e24722. PubMed ID: 36181275
[TBL] [Abstract][Full Text] [Related]
2. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
Front Immunol; 2022; 13():961695. PubMed ID: 36389709
[TBL] [Abstract][Full Text] [Related]
3. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
4. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy.
Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y
Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298
[TBL] [Abstract][Full Text] [Related]
5. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
[TBL] [Abstract][Full Text] [Related]
6. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
[TBL] [Abstract][Full Text] [Related]
7. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-derived molecular subtype and gene signature characterize prognoses and therapeutic responses in head and neck squamous cell carcinoma.
Zou J; Chu S; Zhou H; Zhang Y
Medicine (Baltimore); 2024 Feb; 103(6):e37233. PubMed ID: 38335389
[TBL] [Abstract][Full Text] [Related]
9. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Shi Y; Huang J; Hu Y; Shen Y
BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
[TBL] [Abstract][Full Text] [Related]
10. Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs.
Deng H; Wei Z; Du J; Shen Z; Zhou C
Eur J Med Res; 2023 Nov; 28(1):548. PubMed ID: 38017579
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas.
Wei Z; Zhou C; Shen Y; Deng H; Shen Z
Medicine (Baltimore); 2023 Sep; 102(36):e34790. PubMed ID: 37682196
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
13. Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC.
Chi H; Peng G; Song G; Zhang J; Xie X; Yang J; Xu J; Zhang J; Xu K; Wu Q; Yang G
Front Biosci (Landmark Ed); 2024 Mar; 29(3):130. PubMed ID: 38538268
[TBL] [Abstract][Full Text] [Related]
14. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
15. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B; Li H; Qiao J; Meng T; Yu R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
[TBL] [Abstract][Full Text] [Related]
16. Identification of several senescence-associated genes signature in head and neck squamous cell carcinoma.
Wang J; Zhou CC; Sun HC; Li Q; Hu JD; Jiang T; Zhou S
J Clin Lab Anal; 2022 Jul; 36(7):e24555. PubMed ID: 35692082
[TBL] [Abstract][Full Text] [Related]
17. A novel hypoxia-associated gene signature for prognosis prediction in head and neck squamous cell carcinoma.
Luo J; Huang Y; Wu J; Dai L; Dong M; Cheng B
BMC Oral Health; 2023 Nov; 23(1):864. PubMed ID: 37964257
[TBL] [Abstract][Full Text] [Related]
18. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy.
Ma H; Xiong L; Zhao B; Hahan Z; Wei M; Shi H; Yang S; Ren Q
Front Immunol; 2024; 15():1364082. PubMed ID: 38562924
[TBL] [Abstract][Full Text] [Related]
20. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
